Poly(hydroxyethyl aspartamide) derivatives as colloidal drug carrier systems

被引:50
作者
Cavallaro, G
Licciardi, M
Giammona, G
Caliceti, P
Semenzato, A
Salmaso, S
机构
[1] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy
[2] Univ Palermo, Dept Pharmaceut Technol & Chem, I-90123 Palermo, Italy
关键词
polyaspartamide copolymers; polymeric micelle; colloids; drug delivery;
D O I
10.1016/S0168-3659(03)00121-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poly(hydroxyethylaspartamide) (PHEA) derivatives bearing at the polyaminoacidic backbone poly(ethyleneglycol) (2000 or 5000 Da) or both poly(ethyleneglycol) and hexadecylalkylamine as pendant moieties were investigated as polymeric colloidal drug carriers. The ability of the PHEA derivatives to solubilize hydrophobic drugs was investigated using paclitaxel, amphotericin B and methotrexate. The results demonstrated that the drug solubility depends on both macromolecule composition and drug physicochemical properties. In particular, PEG/hexadecylalkylamine co-graftimg increased significantly the solubilization proper-ties of PHEA for the considered drugs while the conjugation of PEG only did not endow PHEA with drug carrier properties. A stability study carried out with paclitaxel/PHEA-PEG(5000)-hexadecylalkylamine demonstrated that the drug/carrier system is characterized by physicochemical instability, which is strictly related to the incubation pH. However, the carrier was found to partially prevent drug degradation. Investigations performed using murine myeloid leukaemia NFS-60 cell line showed that paclitaxel loaded PHEA-PEG(5000)-hexadecylalkylamine possesses high pharmacological activity with IC50 value of 22.3 ng/ml. Pharmacokinetic studies carried out by intravenous administration of paclitaxel loaded PHEA-PEG(5000)-hexadecylalkylamine to Balb/c mice demonstrated that the carrier modifies the in vivo paclitaxel fate. In particular, PHEA-PEG(5000)-hexadecylalkylamine prolonged the drug distribution and elimination phase of 6 and 17 times, respectively; in addition, it increased the systemic availability (AUC) by about 30 times. (C) 2003 Elsevier Science B.V. All tights reserved.
引用
收藏
页码:285 / 295
页数:11
相关论文
共 37 条
[11]   Preparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugate [J].
Dosio, F ;
Brusa, P ;
Crosasso, P ;
Arpicco, S ;
Cattel, L .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (03) :293-304
[12]  
GIAMMONA G, 1995, J CONTROL RELEASE, V33, P261, DOI 10.1016/0168-3659(94)00091-8
[13]   Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies [J].
Giammona, G ;
Cavallaro, G ;
Fontana, G ;
Pitarresi, G ;
Carlisi, B .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :321-331
[14]   Glycidyl methacrylate derivatization of alpha,beta-poly(N-hydroxyethyl)-DL-aspartamide and alpha,beta-polyasparthydrazide [J].
Giammona, G ;
Tomarchio, V ;
Pitarresi, G ;
Cavallaro, G .
POLYMER, 1997, 38 (13) :3315-3323
[15]   REACTION OF ALPHA, BETA-POLY(N-HYDROXYETHYL)-DL-ASPARTAMIDE WITH DERIVATIVES OF CARBOXYLIC-ACIDS [J].
GIAMMONA, G ;
CARLISI, B ;
PALAZZO, S .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 1987, 25 (10) :2813-2818
[16]  
Giammona G, 2000, POLYM INT, V49, P93, DOI 10.1002/(SICI)1097-0126(200001)49:1<93::AID-PI299>3.0.CO
[17]  
2-6
[18]  
Guillemard V, 2001, CANCER RES, V61, P694
[19]   Polymeric micelles - a new generation of colloidal drug carriers [J].
Jones, MC ;
Leroux, JC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 48 (02) :101-111
[20]   Block copolymer micelles for drug delivery: design, characterization and biological significance [J].
Kataoka, K ;
Harada, A ;
Nagasaki, Y .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :113-131